Krystal Biotech Inc (KRYS) - News Archive

Krystal Biotech, Inc., a biopharmaceutical company based in Pittsburgh, announced on October 14, 2025, that the U.S. Food and Drug Administration (FDA) has granted platform technology designation to its innovative gene...

In a significant development for genetic medicine, Krystal Biotech, Inc. a pioneering biotechnology firm based in Pittsburgh, has received a positive opinion from the European Medicines Agency s (EMA) Committee for Medi...

In a groundbreaking announcement, Krystal Biotech, a clinical-stage biotechnology company, has unveiled remarkable early evidence of monotherapy activity in heavily pre-treated patients with advanced non-small cell lung...

In a landmark development for the treatment of Alpha-1 Antitrypsin Deficiency (AATD), Krystal Biotech has announced promising early clinical findings from its innovative gene therapy programs, KB408 and KB407. These fin...

Jeune Aesthetics Unveils a New Era in Anti-Aging: Phase 1 Breakthrough Results for KB301In an era where the quest for youthfulness and ageless beauty has gained unprecedented momentum, Jeune Aesthetics has unveiled posi...

Krystal Biotech s Promising Advances in Gene Therapy: A Closer Look at Recent DevelopmentsIn an exciting update for both the biotechnology and healthcare sectors, Krystal Biotech, Inc. recently announced its financial r...

In a positive turn of events for the global oncology field, Krystal Biotech, a forward-thinking Carnegie Mellon spinoff focused on pioneering gene therapeutics, has announced the administration of the first dose to a pa...

Krystal Biotech s Groundbreaking B-VEC Treatment: A Promising Breakthrough for Ocular Complications in Dystrophic Epidermolysis Bullosa PatientsKrystal Biotech has recently published a groundbreaking study in the presti...

PITTSBURGH, Dec. 19, 2023 - Krystal Biotech Inc, a leading biotechnology company specializing in the development of genetic medicines for diseases with high unmet medical needs, has announced that it has been granted Or...

PITTSBURGH, Nov. 27, 2023 – Krystal Biotech, Inc. (NASDAQ: KRYS), a renowned biotechnology firm specializing in the discovery, development, and commercialization of genetic medicines to address diseases with significant...